A US-based pharmaceuticals firm is all set to resubmit the world's first female sex drug for the US Food and Drug Administration's (FDA) approval. The once-daily, non-hormonal pill called flibanserin developed by North Carolina-based Sprout Pharmaceuticals, once approved, will be the first prescription of its kind to treat women with Hypoactive Sexual Desire Disorder (HSDD) or low sex drive, th ... Read More
No comments:
Post a Comment